CSL Limited (ASX:CSL)
Pharmaceuticals, Biotechnology & Life Sciences
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) share price
CSL Limited (ASX:CSL) share price news
ASX Growth Shares
Why this top fund manager holds Afterpay (ASX:APT) and Xero (ASX:XRO) shares
Top performing fund manager, Hyperion Asset Management, recently released an update on their Hyperion Australian Growth Companies Fund.
September 18, 2020
ASX Growth Shares
CSL (ASX:CSL) will supply COVID-19 vaccine to Australia
CSL Limited (ASX:CSL) has revealed that it will manufacture and supply COVID-19 vaccines to Australia.
September 7, 2020
ASX Growth Shares
ASX Reporting Season Recap (video): JBH, KGN, EML & PME
In the second installment of our ASX Reporting Season Results Recap, myself and Wattle Partners financial adviser Drew Meredith, look at the reports from EML Payments Ltd (ASX:EML), Kogan.com Ltd (ASX:KGN), Pro Medicus Ltd (ASX:PME) and JB Hi-Fi Limited (ASX:JBH).
August 21, 2020
Today's ASX news
S&P/ASX 200 morning report – 8 ASX shares that reported on Wednesday
The S&P/ASX 200 (INDEXASX: XJO) is set to take a backwards step at the open. It was a busy day yesterday as a number of companies released their annual results. Here’s what you missed.
August 20, 2020
ASX Growth Shares
CSL shares are the gift that keeps on giving
CSL Limited (ASX: CSL) shares solidified their position of one of Australia’s true global leaders.
August 19, 2020
ASX Growth Shares
FY20 report: Is the CSL (ASX:CSL) share price a buy?
CSL Limited (ASX:CSL) has reported its FY20 report to investors, is the CSL share price a buy?
August 19, 2020
ASX Growth Shares
Is it even worth investing in ASX blue chips these days?
ASX blue chips have attracted investors for decades. But are they even worth investing in these days?
August 17, 2020
Today's ASX news
S&P/ASX 200 to open flat – 6 ASX shares to watch
The S&P/ASX 200 (INDEXASX: XJO) is set to open flat on Tuesday. Qantas Airways Limited (ASX: QAN) and Kogan.com Ltd (ASX: KGN) are in the news.
August 11, 2020
Today's ASX news
S&P/ASX 200 morning report – US tech giants report blowout earnings
The S&P/ASX 200 (INDEXASX: XJO) is expected to take a backwards step when the market opens on Friday. Over in the US, big tech stocks like Amazon and Apple have crushed earnings expectations.
July 31, 2020